Literature DB >> 8052060

Hyperthyroxinemia after surgery for primary hyperparathyroidism.

A Bergenfelz1, B Ahrén.   

Abstract

Episodes of transient thyrotoxicosis after surgery for primary hyperparathyroidism have previously been described, and surgical trauma to the thyroid gland has been suggested as an etiologic factor. However, there are several links between the thyroid and parathyroid hormonal systems, and therefore other explanations are possible as well. In this study we investigate pre- and postoperative serum levels of thyroid hormones in 20 patients operated upon because of primary hyperparathyroidism. The mean (SD) serum levels of T4 increased from 16(2) pmol/l preoperatively to 21(6) pmol/l on the fourth postoperative day (P < 0.01), and four (20%) of the patients developed biochemical thyrotoxicosis in the immediate postoperative period. The serum levels of T4 on the fourth postoperative day correlated highly with preoperative serum levels of PTH (r = 0.75; P < 0.001). This suggests that biochemical thyrotoxicosis in the immediate postoperative period after operation for primary hyperparathyroidism is not uncommon and could be related to the disease rather than to surgical trauma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8052060     DOI: 10.1007/bf00680115

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  8 in total

1.  Effect of acute hypercalcemia on thyrotropin (TSH) and triiodothyronine responses to TSH-releasing hormone in man.

Authors:  C Gillet; J Corvilain; J Matte-Hiriart; D Willems; P Bergmann
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

2.  Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients.

Authors:  A Bergenfelz; N E Nordén; B Ahrén
Journal:  Eur J Surg       Date:  1991-02

3.  Postparathyroidectomy transient thyrotoxicosis.

Authors:  P G Walfish; D Caplan; I B Rosen
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

4.  Low basal thyrotropin with normal thyroid function in primary hyperparathyroidism.

Authors:  C Gillet; P Bergmann; D Francois; J J Body; J Corvilain
Journal:  Acta Endocrinol (Copenh)       Date:  1989-11

Review 5.  The role of the pathologist in diagnosis and surgical decision making in hyperparathyroidism.

Authors:  L Grimelius; G Akerström; L Bondeson; C Juhlin; H Johansson; S Ljunghall; J Rastad
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

6.  Serum thyroid hormone indexes in patients with primary hyperparathyroidism.

Authors:  E M Kaptein; S G Massry; H Quion-Verde; F R Singer; E I Feinstein; J T Nicoloff; C F Sharp
Journal:  Arch Intern Med       Date:  1984-02

7.  Surgical strategy in hyperparathyroidism due to solitary adenoma.

Authors:  S Tibblin; A G Bondeson; L Bondeson; O Ljungberg
Journal:  Ann Surg       Date:  1984-12       Impact factor: 12.969

8.  Effects of disodium EDTA and calcium infusion on prolactin and thyrotropin responses to thyrotropin-releasing hormone in healthy man.

Authors:  R Dudczak; W K Waldhäusl; P Bratusch-Marrain
Journal:  J Clin Endocrinol Metab       Date:  1983-03       Impact factor: 5.958

  8 in total
  4 in total

Review 1.  Thyrotoxicosis after parathyroidectomy mimicking myocardial infarction: a case report and review of the literature.

Authors:  A Kauffels; I O Lee; M K Schilling; J E Slotta
Journal:  Clin Res Cardiol       Date:  2012-03-22       Impact factor: 5.460

2.  Transient hyperthyroidism after total parathyroidectomy for tertiary hyperparathyroidism: a report of two cases.

Authors:  Stephan R Lederer; Helmut Schiffl
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

3.  Post-parathyroidectomy thyrotoxicosis and atrial flutter: a case for caution.

Authors:  Abdo Asmar; Edward A Ross
Journal:  NDT Plus       Date:  2011-04

4.  Transient Thyroiditis after Surgery for Tertiary Hyperparathyroidism: A Case Report.

Authors:  Yasser Ali Hakami
Journal:  Front Endocrinol (Lausanne)       Date:  2015-08-18       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.